Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) ("Aurinia" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has approved LUPKYNIS^TM (voclosporin) in combination with a background immunosuppressive therapy regimen to treat adult patients with active lupus nephritis (LN).

Did Aurinia Pharmaceuticals Get FDA approved?

Aurinia Makes History as FDA Approves First Oral Drug for Lupus Nephritis. Shares of Aurinia Pharmaceuticals soared more than 40% in premarket trading following the regulatory approval of the company's treatment for adult patients with active lupus nephritis (LN).

Will voclosporin be approved?

The FDA has approved Aurinia Pharmaceuticals' Lupkynis^TM(voclosporin) for the treatment of lupus nephritis, alongside standard-of-care.

When was Lupkynis approved by the FDA?

Multimedia components are available with this press release (link here). Aurinia will host a conference call and webcast to discuss the approval of LUPKYNIS on Monday, January 25, 2021 at 8:30 a.m. ET.

What is the new medication for lupus?

The U.S. Food and Drug Administration (FDA) has approved Saphnelo™ (anifrolumab-fnia) as a treatment for adults with systemic lupus erythematosus (SLE) who are receiving standard therapy.

Aurinia (AUPH) and Selena Gomez? Voclosporin is FDA Approved!

20 related questions found

Is Anifrolumab FDA approved?

The FDA has approved AstraZeneca's anifrolumab for adults with moderate to severe systemic lupus erythematosus (SLE) who are receiving standard therapy. This is the first new approval for these patients in 10 years, and just the second in the past 60 years.

Is Cabotegravir FDA approved?

The FDA set a target approval date of January 24, 2022, and if approved, cabotegravir will be the first long-acting therapy for HIV prevention. Cabotegravir is an injectable form of pre-exposure prophylaxis (PrEP) intended for individuals at risk of sexually acquired HIVinfection.

What is the cause of lupus nephritis?

Lupus nephritis is a type of kidney disease caused by systemic lupus erythematosus link (SLE or lupus). Lupus is an autoimmune disease link—a disorder in which the body's immune system attacks the body's own cells and organs. Kidney disease caused by lupus may get worse over time and lead to kidney failure.

What drugs are approved for lupus nephritis?

Treatments for lupus nephritis include immunosuppressive drugs such as glucocorticoids, cyclophosphamide, mycophenolate, and azathioprine. Belimumab and voclosporin are FDA-approved specifically for lupus nephritis.

What is Lupkynis?

Lupkynis is a drug developed to treat lupus nephritis, a lupus-related kidney disease caused by inflammation. It is taken as a pill in combination with standard of care therapies and works by suppressing the immune system.

Is Cabotegravir approved for PrEP?

Cabotegravir long-acting for PrEP has not been approved or licensed anywhere in the world for use in HIV prevention.

Is Cabenuva covered by Medicare?

the cost of the injections). For Medicare clients, Cabenuva is expected to be covered under Part B as a physician-administered drug, though some Medicare Advantage plans may opt to cover Cabenuva under Part D. Medicaid coverage policies will be determined on a state-by-state basis.

Is Cabenuva available in the US?

FDA cleared Cabenuva, the first and only compete long-acting regimen to treat HIV-1 in adults, according to pharma maker ViiV Healthcare.

How long can you take Benlysta?

Belimumab works by reducing the activity of a type of white blood cell called B-cells that produce the antibodies. This reduces the inflammation that causes the symptoms of lupus. It's a long-term treatment, so it may be up to six months before you start to notice the benefits.

Does benlysta cause hair loss?

Hair loss is a rare side effect some people may experience while taking Benlysta. In clinical trials, no one reported hair loss. However, since the drug was approved, three people have reported hair loss while taking Benlysta. Specifically, the type of hair loss that was reported is called alopecia areata.

What happens when you stop taking Benlysta?

Heart problems: chest discomfort or pain, shortness of breath, cold sweats, nausea, dizziness, or discomfort in other areas of the upper body.

How long do lupus SLE patients live?

For people with lupus, some treatments can increase the risk of developing potentially fatal infections. However, the majority of people with lupus can expect a normal or near-normal life expectancy. Research has shown that many people with a lupus diagnosis have been living with the disease for up to 40 years.

Is Saphnelo an immunosuppressant?

Saphnelo 300 Mg/2 Ml (150 Mg/Ml) Intravenous Solution Immunosuppressive - Interferon Inhibitor, Monoclonal Ab - Uses, Side Effects, and More.

How is lupus cured?

Lupus is a chronic disease with no cure.

This means that you can manage it with treatment, but it will not go away. Treatment can help improve your symptoms, prevent flares, and prevent other health problems often caused by lupus.

What vitamins help with lupus?

Vitamin E, zinc, vitamin A, and the B vitamins are all beneficial in a lupus diet. Vitamin C can increase your ability to absorb iron and is a good source of antioxidants.

Why are people with lupus so tired?

Inflammation: Any time your body is experiencing excess inflammation, such as during a lupus flare, you will feel more tired. Anemia: Anemia occurs when your red blood cell count gets low. This means that the amount of oxygen going to your organs will decrease, which can increase your level of fatigue.

What drugs are FDA approved for lupus?

The FDA approved Benlysta (belimumab)—the first targeted therapy for lupus—in 2011 to treat systemic lupus in adults. The FDA later approved Benlysta to treat children with lupus down to 5 years of age.

Who HPTN 084?

HPTN 084-01 (The LIFT Study) is a clinical trial examining whether injectable cabotegravir (CAB) for PrEP (pre-exposure prophylaxis) is safe and acceptable for adolescent females (assigned female at birth).